Comparative Study Sheds New Light on Ulcerative Colitis
In April 2025, guselkumab, a human monoclonal antibody targeting the interleukin-23 (IL-23) pathway, received approval for the treatment of adults ...
In April 2025, guselkumab, a human monoclonal antibody targeting the interleukin-23 (IL-23) pathway, received approval for the treatment of adults ...
In a groundbreaking study poised to redefine our understanding of intestinal health, researchers have uncovered a novel microbiota-mediated pathway that ...
In the relentless pursuit of novel antibiotics to combat the rising tide of antibiotic-resistant infections, scientists have unveiled a promising ...
In recent years, the emergence of Janus kinase (JAK) inhibitors has revolutionized the treatment landscape for various autoimmune disorders, including ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine